+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Motion Sickness Drug"

Motion Sickness Treatment: Global Strategic Business Report - Product Thumbnail Image

Motion Sickness Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 197 Pages
  • Global
From
Global Motion Sickness Drugs Market 2023-2027 - Product Thumbnail Image

Global Motion Sickness Drugs Market 2023-2027

  • Report
  • May 2023
  • 160 Pages
  • Global
From
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

The Motion Sickness Drug market is a subset of the Over the Counter (OTC) Drug market. These drugs are used to treat the symptoms of motion sickness, such as nausea, dizziness, and vomiting. Common ingredients in these drugs include dimenhydrinate, meclizine, and scopolamine. These drugs are available in a variety of forms, including tablets, capsules, and patches. They are often used to prevent motion sickness before it occurs, as well as to treat it once it has started. Some of the companies in the Motion Sickness Drug market include Johnson & Johnson, GlaxoSmithKline, Bayer, Pfizer, and Novartis. These companies produce a variety of motion sickness drugs, including Dramamine, Bonine, and Transderm Scop. Show Less Read more